title: Erratum to: FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn's disease through affecting the ADCC activity.
authors.affiliation: Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan, rinta@med.tohoku.ac.jp.
authors.forename: Rintaro
authors.initials: R
authors.lastname: Moroi
authors.forename: Katsuya
authors.initials: K
authors.lastname: Endo
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Kinouchi
authors.forename: Hisashi
authors.initials: H
authors.lastname: Shiga
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Kakuta
authors.forename: Masatake
authors.initials: M
authors.lastname: Kuroha
authors.forename: Yoshitake
authors.initials: Y
authors.lastname: Kanazawa
authors.forename: Yosuke
authors.initials: Y
authors.lastname: Shimodaira
authors.forename: Takahiko
authors.initials: T
authors.lastname: Horiuchi
authors.forename: Seiichi
authors.initials: S
authors.lastname: Takahashi
authors.forename: Tooru
authors.initials: T
authors.lastname: Shimosegawa